Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Paltusotine [inn]
2. F2ibd1gmd3
3. 2172870-89-0
4. 3-(4-(4-aminopiperidin-1-yl)-3-(3,5-difluorophenyl)quinolin-6-yl)-2-hydroxybenzonitrile
5. Benzonitrile, 3-(4-(4-amino-1-piperidinyl)-3-(3,5-difluorophenyl)-6-quinolinyl)-2-hydroxy-
6. 3-[4-(4-aminopiperidin-1-yl)-3-(3,5-difluorophenyl)quinolin-6-yl]-2-hydroxybenzonitrile
7. Unii-f2ibd1gmd3
8. Schembl19769109
9. Bdbm405588
10. Crn-00808
11. Us10351547, Compound 2-2
12. Hy-109155
13. Cs-0116068
Molecular Weight | 456.5 g/mol |
---|---|
Molecular Formula | C27H22F2N4O |
XLogP3 | 5.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 456.17616766 g/mol |
Monoisotopic Mass | 456.17616766 g/mol |
Topological Polar Surface Area | 86.2 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 727 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Paltusotine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Paltusotine, including repackagers and relabelers. The FDA regulates Paltusotine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Paltusotine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Paltusotine supplier is an individual or a company that provides Paltusotine active pharmaceutical ingredient (API) or Paltusotine finished formulations upon request. The Paltusotine suppliers may include Paltusotine API manufacturers, exporters, distributors and traders.
Paltusotine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Paltusotine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Paltusotine GMP manufacturer or Paltusotine GMP API supplier for your needs.
A Paltusotine CoA (Certificate of Analysis) is a formal document that attests to Paltusotine's compliance with Paltusotine specifications and serves as a tool for batch-level quality control.
Paltusotine CoA mostly includes findings from lab analyses of a specific batch. For each Paltusotine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Paltusotine may be tested according to a variety of international standards, such as European Pharmacopoeia (Paltusotine EP), Paltusotine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Paltusotine USP).
LOOKING FOR A SUPPLIER?